Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.86), $0.28 worse than the analyst estimate of ($1.58).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.